JeffreySHeierMD

Clinical Trials

• Safety Study of Ranibizumab Eye Injections to Treat Choroidal Neovascularization That Was Caused Other Than by Age-Related Macular Degeneration. Start of enrollment: 2005 Dec 01

  Completed

  Phase 1

• Safety Study of Bromfenac Ophthalmic Solution in Subjects With Diffuse Diabetic Macular Edema (DME) Refractory to Laser Start of enrollment: 2007 Jun 01

  Unknown status

  Phase 1

• A Study to Evaluate the Neovista Ophthalmic System for the Treatment of Subfoveal CNV in Patients With AMD That Have Failed Primary Anti-VEGF Therapy Start of enrollment: 2007 Dec 01

  Completed

  Phase 2

• Phase I Study of Palomid 529 a Dual TORC1/2 Inhibitor of the PI3K/Akt/mTOR Pathway for Advanced Neovascular Age-Related Macular Degeneration Start of enrollment: 2010 Jun 01

  Completed

  Phase 1

• A Safety and Efficacy Assessment of Resolvine for Treatment of Vitreomacular Attachment Start of enrollment: 2013 Oct 01

  Completed

  Phase 1

• Ocriplasmin Research to Better Inform Treatment (ORBIT) Start of enrollment: 2014 May 01

  Completed

• A Retrospective Chart Review of Patients Treated With Ocriplasmin for Symptomatic VMA Start of enrollment: 2014 Aug 01

  Completed

• TLC399 (ProDex) in Subjects With Macular Edema Due to Retinal Vein Occlusion (RVO) Start of enrollment: 2017 Apr 01

  Completed

  Phase 2

• The GUARD Trial - Part 1: A Phase 3 Clinical Trial for Prevention of Proliferative Vitreoretinopathy Start of enrollment: 2019 Nov 15

  Completed

  Phase 3

• Join now to see all